Wiener klinische Wochenschrift

, Volume 122, Issue 7, pp 194–197

Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?

Authors

    • Abteilung Nephrologie und DialyseMedizinische Universität Wien
Perspective

DOI: 10.1007/s00508-010-1365-6

Cite this article as:
Bielesz, B. Wien Klin Wochenschr (2010) 122: 194. doi:10.1007/s00508-010-1365-6

Keywords

Chronic kidney failureVitamin DCardiovascular diseaseParathyroid hormoneHemodialysis

Copyright information

© Springer-Verlag 2010